SCPH — SCPHARMACEUTICALS INC

Ownership history in XTX Topco Ltd  ·  5 quarters on record

This page tracks every 13F SEC filing in which XTX Topco Ltd reported a position in SCPHARMACEUTICALS INC (SCPH). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.12% (2022 Q4)
Avg. % of fund
0.03%
First filed
2022 Q4
Last filed
2025 Q3
Quarters held
5
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 65,062 +33,306 +104.9% 0.02% $369K —
2025 Q2 ADDED 31,756 +4,225 +15.3% 0.01% $121K —
2024 Q4 ADDED 27,531 +362 +1.3% 0.01% $97K —
2024 Q3 REDUCED 27,169 -49,340 -64.5% 0.01% $124K —
1 older quarter hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)

Other funds also holding SCPH

As of 2025 Q3 — sorted by position size

Yakira Capital Management, Inc. 3Y 7Y 0.87% ORBIMED ADVISORS LLC 3Y 7Y 0.81% Tejara Capital Ltd 3Y 0.73% Newtyn Management, LLC 3Y 7Y 0.65% APIS CAPITAL ADVISORS, LLC 3Y 7Y 0.55% Rangeley Capital, LLC 0.46% Balanced Rock Investment Advisors LLC 0.34% ALPINE ASSOCIATES MANAGEMENT INC. 3Y 7Y 0.33% Rubric Capital Management LP 3Y 7Y 0.33% GABELLI & Co INVESTMENT ADVISERS, INC. 3Y 7Y 0.28%
← Back to XTX Topco Ltd Holdings